Presentation TCT 2024 Novel Technology to Enable Atrioventricular Valve Replacement After TEER Therapy (AMX Technologies) (68998) Presenter: Paul Sorajja October 27, 2024
Presentation TCT 2024 Impact of Pullback Pressure Gradient on Patient-Reported Outcomes in Patients With Coronary Artery Disease Presenter: Carlos Collet October 27, 2024
Presentation TCT 2024 Multicenter Prospective Assessment of Coronary Microvascular Dysfunction: Primary Results of the FlowLab Study Presenter: Brian Bergmark October 27, 2024
Presentation TCT 2024 Prospective Randomized Trial Evaluating Clinical Outcomes of Angiography-Based Fractional Flow Reserve Guidance Versus Wire-Based Fractional Flow Reserve Guidance: The PROVISION Trial Presenter: Hitoshi Matsuo October 27, 2024
Presentation TCT 2024 ORBITA2-PHYSIOLOGY: Fractional Flow Reserve and Instantaneous Wave-Free Ratio as Predictors of the Placebo-Controlled Response to Percutaneous Coronary Intervention in Stable Coronary Artery Disease Presenter: Michael Foley October 27, 2024
Presentation TCT 2024 Coronary Physiological Indices to Evaluate Myocardial Ischemia in Patients With Aortic Valve Stenosis Undergoing Valve Replacement: The COMIC-AS Study Presenter: Lennert Minten October 27, 2024
Presentation TCT 2024 Patient Reported Outcomes in National Registries: Why and How? Presenter: Joan Michaels October 27, 2024
Presentation TCT 2024 Shared Decision-Making: A Toolkit for the Heart Team Presenter: Megan Coylewright October 27, 2024
Presentation TCT 2024 Closing the Gap Between Good Intentions and Implementation Presenter: Sandra Lauck October 27, 2024
Presentation TCT 2024 TCT 1490: From the Valve to the Basket: Combined Transcatheter Mitral Valve Lithotripsy and Percutaneous Balloon Valvuloplasty for Palliative Treatment of Severe Calcified Degenerative Mitral Valve Stenosis Presenter: Gerardo V. Lo Russo October 27, 2024